However, they are also found in adults with certain kinds of cancer. These proteins are often measurable in blood of individuals with cancer and may be used to both diagnose and follow treatment of the tumors. The use of oncofetal proteins is an 'Achilles heel' of cancer and these proteins are promising targets for several types of cancers. AFPR is an ideal immunotherapy target [11] . AFP-toxin drugs were successfully used for anti-cancer targeted chemotherapy [12] .
However, oncofetal proteins are of critical importance not only in pregnancy and tumor growth.
Utilization of its physiological delivery function makes AFP a highly promising carrier that can be used for immune suppression during autoimmune and other MDSC-mediated diseases treatments [13, 14] . It should be noted that other oncofetal proteins also serve as immune modulators, for example human chorionic gonadotropin (hCG) eventually contributes to peripheral immune tolerance development [15] .
Placenta-produced pregnancy-associated plasma protein A (PAPP-A) shares mechanisms of immune evasion with cancer cells [16] ; trophoblastic b1-glycoprotein (PSG) determines differentiation and maturity of naive T-cells in memory T cells [17] , etc. 
Conclusion

